wedge
Spinal Cord Injury - SCI - CNS Preclinical CRO
Spinal Cord Injury - SCI - CNS Preclinical CRO BIOTROFIX - Premier Preclinical CRO - Stroke, Alzheimer's, ALS, TBI Research - Seth P. Finklestein, M.D., CEO Spinal Cord Injury - SCI - CNS Preclinical CRO Spinal Cord Injury (SCI) Animal Models & CRO Services - CRO Preclinical Research
Spinal Cord Injury - SCI - CNS Preclinical CRO Spinal Cord Injury - SCI - CNS Preclinical CRO Spinal Cord Injury - SCI - CNS Preclinical CRO Spinal Cord Injury - SCI - CNS Preclinical CRO Spinal Cord Injury - SCI - CNS Preclinical CRO
 
Home
greybar
The Company
greybar
Preclinical Research Services
PK/PD Studies
Acute Stroke
Stroke Recovery
Intracerebral Hemorrhage
Alzheimer's Disease
Amyotrophic Lateral Sclerosis
Traumatic Brain Injury
Spinal Cord Injury
Muscular Dystrophy
Myocardial Infarction
Peripheral Vascular Disease
Others
Will Travel Services
greybar
The Team
greybar
News from Biotrofix
greybar
Publications
greybar
Contact Us


Well-equipped CRO laboratory
 

Spinal Cord Injury (SCI) Animal Models & CRO Services

Spinal Cord Injury (SCI) Animal Models & CRO Services - CRO Preclinical Research About 10,000 Americans suffer traumatic spinal cord injury (SCI) each year. Depending on the level of injury, this can result in permanent paralysis of legs alone, or all four limbs (paraplegia or quadriplegia, respectively). Diving, vehicular, and sports injuries are common causes of SCI. Since many SCI patients are young, they often survive for many years following injury, leading to considerable suffering and medical expenses for the patients and their families.

Biotrofix is experienced in rodent models of SCI. Endpoints for these models are behavioral (tests of motor strength and dexterity) and histological (evidence of neural damage in spinal cord and axonal regeneration). These models are particularly suited to testing neural regrowth and regeneration-producing strategies.

 

 
 
Home | The Company | Preclinical Research Services | The Team | News | Publications | Contact Us | Site Map
wedgeBiotrofix, Inc. 604 Webster Street, Needham, MA 02494 Tel: 781-786-8890 Fax: 781-465-6061


Biotrofix is a premier preclinical contract research organization specializing in animal models of CNS, cardiac and vascular disease. With years of experience, both academic, commercial, clients throughout the biotech and pharmaceutical industries, Biotrofix delivers industry-leading preclinical CRO services, including rodent models of acute stroke and stroke recovery, preclinical CRO services for Alzheimer's Disease, transgenic animal models for ALS, as well as CRO services for brain injury, preclinical CRO services for spinal cord injury and related cardiac drug discovery and development.